449 related articles for article (PubMed ID: 19637949)
1. Overcoming drug resistance in patients with metastatic breast cancer.
Wong ST; Goodin S
Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.
Coley HM
Cancer Treat Rev; 2008 Jun; 34(4):378-90. PubMed ID: 18367336
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
4. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
Gligorov J; Lotz JP
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
[TBL] [Abstract][Full Text] [Related]
5. The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies.
Fojo T; Coley HM
Clin Breast Cancer; 2007 Oct; 7(10):749-56. PubMed ID: 18021475
[TBL] [Abstract][Full Text] [Related]
6. Target-based therapies in breast cancer: current status and future perspectives.
Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
[TBL] [Abstract][Full Text] [Related]
7. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?
Bedard PL; Freedman OC; Howell A; Clemons M
Breast Cancer Res Treat; 2008 Apr; 108(3):307-17. PubMed ID: 18351454
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline resistance: the problem and its current definition.
Gianni L
Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-11-S10-17. PubMed ID: 9275001
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
10. Overview of tumor cell chemoresistance mechanisms.
Gatti L; Zunino F
Methods Mol Med; 2005; 111():127-48. PubMed ID: 15911977
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the efficacy of hormonal agents with selected targeted agents.
Johnston SR
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S28-36. PubMed ID: 19561004
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies in breast cancer.
Tripathy D
Breast J; 2005; 11 Suppl 1():S30-5. PubMed ID: 15725114
[TBL] [Abstract][Full Text] [Related]
14. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
16. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.
El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E
Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240
[TBL] [Abstract][Full Text] [Related]
17. Facts and controversies in systemic treatment of metastatic breast cancer.
Bernard-Marty C; Cardoso F; Piccart MJ
Oncologist; 2004; 9(6):617-32. PubMed ID: 15561806
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy resistance in breast cancer.
Lehnert M
Anticancer Res; 1998; 18(3C):2225-6. PubMed ID: 9703789
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer.
Uzzo RG; Haas NB; Crispen PL; Kolenko VM
Cancer; 2008 Apr; 112(8):1660-71. PubMed ID: 18278811
[TBL] [Abstract][Full Text] [Related]
20. Fluoropyrimidine resistance in colon cancer.
Gorlick R; Banerjee D
Expert Rev Anticancer Ther; 2002 Aug; 2(4):409-16. PubMed ID: 12647984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
